CA2189067A1 - Vecteur d'apport de genes utilisant un adn plasmidique encapsule dans un adenovirus et une lignee cellulaire d'encapsidation - Google Patents

Vecteur d'apport de genes utilisant un adn plasmidique encapsule dans un adenovirus et une lignee cellulaire d'encapsidation

Info

Publication number
CA2189067A1
CA2189067A1 CA 2189067 CA2189067A CA2189067A1 CA 2189067 A1 CA2189067 A1 CA 2189067A1 CA 2189067 CA2189067 CA 2189067 CA 2189067 A CA2189067 A CA 2189067A CA 2189067 A1 CA2189067 A1 CA 2189067A1
Authority
CA
Canada
Prior art keywords
adenovirus
dna
pseudo
expression vector
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2189067
Other languages
English (en)
Inventor
Gary J. Nabel
Michael J. Imperiale
Takeshi Ohno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan Ann Arbor
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2189067A1 publication Critical patent/CA2189067A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2189067 1994-04-28 1995-04-25 Vecteur d'apport de genes utilisant un adn plasmidique encapsule dans un adenovirus et une lignee cellulaire d'encapsidation Abandoned CA2189067A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23499094A 1994-04-28 1994-04-28
US08/234,990 1994-04-28

Publications (1)

Publication Number Publication Date
CA2189067A1 true CA2189067A1 (fr) 1995-11-09

Family

ID=22883604

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2189067 Abandoned CA2189067A1 (fr) 1994-04-28 1995-04-25 Vecteur d'apport de genes utilisant un adn plasmidique encapsule dans un adenovirus et une lignee cellulaire d'encapsidation

Country Status (4)

Country Link
EP (1) EP0763103A4 (fr)
JP (1) JPH10507061A (fr)
CA (1) CA2189067A1 (fr)
WO (1) WO1995029993A1 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670488A (en) * 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
US20020164782A1 (en) 1999-02-10 2002-11-07 Gregory Richard J. Adenovirus vectors for gene therapy
US7252989B1 (en) 1994-04-04 2007-08-07 Board Of Regents, The University Of Texas System Adenovirus supervector system
WO1996013597A2 (fr) * 1994-10-28 1996-05-09 The Trustees Of The University Of Pennsylvania Adenovirus recombine et ses procedes d'utilisation
DE69628744D1 (de) * 1995-04-17 2003-07-24 Univ Texas System Austin Board Adenovirus helfervirus system
WO1997029701A1 (fr) 1996-02-15 1997-08-21 Biosense Inc. Procede de chirurgie par catheter
US6228646B1 (en) * 1996-03-07 2001-05-08 The Regents Of The University Of California Helper-free, totally defective adenovirus for gene therapy
US6443974B1 (en) 1996-07-28 2002-09-03 Biosense, Inc. Electromagnetic cardiac biostimulation
US6544523B1 (en) 1996-11-13 2003-04-08 Chiron Corporation Mutant forms of Fas ligand and uses thereof
CN1263854C (zh) 1997-11-06 2006-07-12 启龙股份公司 奈瑟球菌抗原
WO1999027101A1 (fr) * 1997-11-25 1999-06-03 Princeton University Procede de preparation de vecteurs d'adenovirus, vecteurs ainsi prepares et leurs utilisations
JP2001526900A (ja) 1997-12-23 2001-12-25 イントロヘーネ ベスローテン フェンノートシャップ 標的細胞の染色体ｄｎａへの外来遺伝子情報の組み込みに有用な、アデノ随伴ウイルスおよびアデノウイルスのキメラ組換えウイルス
AU1979599A (en) 1998-01-14 1999-08-02 Chiron S.P.A. (neisseria meningitidis) antigens
DE69838526T2 (de) 1998-02-05 2008-07-03 Biosense Webster, Inc., Diamond Bar Gerät zum Freisetzen eines Medikaments im Herzen
EP2261352A3 (fr) 1998-05-01 2012-01-04 Novartis Vaccines and Diagnostics, Inc. Antigènes de Neisseria meningitidis et compositions
US6113913A (en) * 1998-06-26 2000-09-05 Genvec, Inc. Recombinant adenovirus
GB9817660D0 (en) 1998-08-13 1998-10-07 Angeletti P Ist Richerche Bio Adenoviral vectors encoding erythropoietin and their use in gene therapy
JP2003518363A (ja) 1999-04-30 2003-06-10 カイロン エセ．ピー．アー． 保存されたナイセリア抗原
GB9911683D0 (en) 1999-05-19 1999-07-21 Chiron Spa Antigenic peptides
GB9916529D0 (en) 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
RU2281956C2 (ru) 1999-10-29 2006-08-20 Чирон С.Р.Л. Антигенные пептиды neisseria
PT2289545T (pt) 2000-01-17 2016-09-06 Glaxosmithkline Biologicals Sa Vacina de omv suplementada contra meningococos
DK1328543T3 (da) 2000-10-27 2009-11-23 Novartis Vaccines & Diagnostic Nukleinsyrer og proteiner fra streptococcus-gruppe A & B
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
CN100515494C (zh) 2001-12-12 2009-07-22 启龙有限公司 抗沙眼衣原体的免疫
GB0308198D0 (en) 2003-04-09 2003-05-14 Chiron Srl ADP-ribosylating bacterial toxin
US8268324B2 (en) 2004-03-29 2012-09-18 Galpharma Co., Ltd. Modified galectin 9 proteins and use thereof
DK2229956T3 (da) 2004-09-13 2013-07-29 Genzyme Corp Multimere konstruktioner
AR059089A1 (es) 2006-01-20 2008-03-12 Genzyme Corp Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal
DK1988823T3 (en) 2006-02-09 2018-12-03 Genzyme Corp SLOW INTRAVENTRICULAR ADMINISTRATION
DK2054431T3 (da) 2006-06-09 2012-01-02 Novartis Ag Konformere af bakterielle adhæsiner
CA2863964C (fr) 2012-02-07 2021-10-26 Global Bio Therapeutics Usa, Inc. Procede compartimente d'administration d'acide nucleique et ses compositions et utilisations
WO2015021443A1 (fr) 2013-08-08 2015-02-12 Global Bio Therapeutics Usa, Inc. Dispositif de serrage pour procédures mini-invasives et utilisations de ce dernier
JP2024531827A (ja) 2021-08-13 2024-08-29 トリオヴァンス ホールディング リミテッド ライアビリティ カンパニー 代用皮膚組成物ならびにそれを製造および使用する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3534749B2 (ja) * 1991-08-20 2004-06-07 アメリカ合衆国 アデノウイルスが介在する胃腸管への遺伝子の輸送
EP0669987B1 (fr) * 1992-09-25 2008-08-13 Aventis Pharma S.A. Vecteurs d'adenovirus pour le transfert de genes etrangers dans des cellules du systeme nerveux central, en particulier du cerveau
FR2705686B1 (fr) * 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.

Also Published As

Publication number Publication date
JPH10507061A (ja) 1998-07-14
EP0763103A4 (fr) 1998-07-15
WO1995029993A1 (fr) 1995-11-09
EP0763103A1 (fr) 1997-03-19

Similar Documents

Publication Publication Date Title
CA2189067A1 (fr) Vecteur d'apport de genes utilisant un adn plasmidique encapsule dans un adenovirus et une lignee cellulaire d'encapsidation
US12195766B2 (en) Tumor-selective E1a and E1b mutants
DE69433461T2 (de) Rekombinanter Alphavirus Vektor
EP1032696B1 (fr) Vecteur pour replication et expression genique a specificite tissulaire
AU716045B2 (en) Vectors for tissue-specific replication
US6156497A (en) Recombinase-mediated generation of adenoviral vectors
US5998205A (en) Vectors for tissue-specific replication
WO1996017053A9 (fr) Vecteurs de replication a specificite tissulaire
IL112860A (en) Defective recombinant adenoviral vectors, their preparation and their therapeutic uses
JPH11508770A (ja) 組織特異的ウイルスベクター
JP2012080889A (ja) 多コンパートメント真核生物発現系
JP4386971B2 (ja) スプライシング配列を含んでなる組換えアデノウイルスベクター
JP2001502883A (ja) ミニアデノウイルスベクター
AU717218B2 (en) Medicinal combination useful for in vivo exogenic transfection and expression
Murphy et al. Cloning vectors for expression of cDNA libraries in mammalian cells.
DE69527544T2 (de) Kombinationsvektoren zum austragen von genmaterial
KR100246096B1 (ko) 유전자 요법을 위한 개선된 레트로바이러스 벡터
JP2002330786A (ja) 抗炎症性ベクター
US20020019051A1 (en) Chimeric adenoviral vectors
JPH10506018A (ja) 不活化ＩＶａ２遺伝子を有する欠陥組換えアデノウィルス
JP2001500021A (ja) 新規な内部リボソームエントリー部位およびそれを含有するベクター
Brady et al. Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus
WO2002008436A2 (fr) Système de vecteur mini-adénoviral pour vaccination
AU747831B2 (en) DNA virus vectors and methods for their preparation
AU747763B2 (en) Method for helper virus-free packaging of a gene vector DNA

Legal Events

Date Code Title Description
FZDE Dead